Zusammenfassung
Patienten mit Neurofibromatose haben ein gegenüber der Normalbevölkerung erhöhtes Risiko, Malignome zu entwickeln. Wir berichten über eine Patientin, bei der sich ein maligner peripherer Nervenscheidentumor aus einem präexistenten Neurofibrom entwickelte.
Abstract
Patients with neurofibromatosis have an increased risk of developing malignant tumors in comparison to the general population. We describe a woman who developed a malignant peripheral nerve sheath tumor in a pre-existing neurofibroma.
Literatur
Coindre JM, Terrier Ph, Guillou L et al (2001) Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas. A study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 91:1914–1926
Cox A (2001) Farnesyltransferase inhibitors: potential role in the treatment of cancer. Drugs 61:723–732
Ducatman B, Scheithauer B, Piepgras D et al (1986) Malignant peripheral nerve sheath tumors: a clinicopathologic study of 120 cases. Cancer 57:2006–2021
Enziger FM, Weiss SW (2001) Benign tumors of peripheral nerves: malignant tumors of the peripheral nerves. In: Weiss SW, Goldblum JR (eds) Soft tissue tumors, 4th edn, Mosby, St. Louis, MO, pp 1111–1263
Ferner RE, Lucas JD, O Doherty MJ et al (2000) Evaluation of 18 fluorodeoxyglucose positron emission tomography in the detection of malignant peripheral nerve sheath tumors in neurofibromatosis. J Neurol Neurosurg Psychiatry 68:353–357
Ferner R, Gutmann D (2002) International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis 1. Cancer Res 62:1573–1577
Ferner RE (2007) Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol 4:340–351
George E, Swanson P, Wick M (1989) Malignant peripheral nerve sheath tumors of the skin. Am J Dermatopathol 11:213–221
Santoro A, Tursz T, Mouridsen H et al (1995) Doxorubicin versus CY VADIC versus doxorubicin plus ifosfamide in the first-line treatment of advanced soft tissue sarcomas: a randomized study of the EORTC Soft Tissue und Bone Sarcoma Group. J Clin Oncol 13:1537–1545
Wojtkowiak JW, Fouad F, Lalonde DT et al (2008) Induction of apoptosis in Neurofibromatosis Typ 1 malignant peripheral nerve shath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin. J Pharmacol Exp Ther (epub ahead of print)
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dietrich, V., Schaller, J. & Kunze, J. Kutaner maligner peripherer Nervenscheidentumor bei Neurofibromatose Typ 1. Hautarzt 60, 830–833 (2009). https://doi.org/10.1007/s00105-008-1700-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-008-1700-2